Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
ID: 357936Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)" aimed at advancing exploratory research in Alzheimer's disease (AD) and related dementias (ADRD). This initiative invites applications for innovative methodologies, animal models, and techniques that require preliminary data, with a focus on addressing health disparities among under-resourced populations. The program emphasizes the importance of interdisciplinary research to combat the public health crisis posed by AD and ADRD, with a maximum funding amount of $275,000 available over two years. Interested applicants must submit their proposals by November 16, 2027, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is issuing a funding opportunity (PAR-25-331) for exploratory research on Alzheimer's disease (AD) and related dementias (ADRD). This initiative aims to advance understanding of these conditions by inviting applications for new methodologies, animal models, or techniques that require further preliminary data. Emphasizing the need for inclusive research, the announcement highlights the urgency to address health disparities among under-resourced populations. Key deadlines for applications start from February 11, 2025, with awards anticipated based on NIH budget availability. The maximum budget for projects is $275,000 over two years, and the program encourages organizations of varied backgrounds, especially those that historically serve diverse populations, to participate. Additionally, it lays out rigorous criteria for evaluating applications based on significance, innovation, scientific quality, and the expertise of the investigator(s). The overarching goal is to support interdisciplinary research and strengthen efforts to combat the impending public health crisis posed by AD and ADRD. The notice stresses compliance with NIH’s regulations and promotes early submission to accommodate potential application corrections.
    Similar Opportunities
    Loading similar opportunities...